DE69631962D1 - Verfahren zur modulation der zell-apoptose - Google Patents

Verfahren zur modulation der zell-apoptose

Info

Publication number
DE69631962D1
DE69631962D1 DE69631962T DE69631962T DE69631962D1 DE 69631962 D1 DE69631962 D1 DE 69631962D1 DE 69631962 T DE69631962 T DE 69631962T DE 69631962 T DE69631962 T DE 69631962T DE 69631962 D1 DE69631962 D1 DE 69631962D1
Authority
DE
Germany
Prior art keywords
apoptosis
cell apoptosis
modulating cell
beta
inhibit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69631962T
Other languages
English (en)
Other versions
DE69631962T2 (de
Inventor
Damme Jo Van
Paul Proost
Frederic Houssiau
Jean-Christophe Renauld
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ludwig Institute for Cancer Research New York
Original Assignee
Ludwig Institute for Cancer Research New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9518611.0A external-priority patent/GB9518611D0/en
Application filed by Ludwig Institute for Cancer Research New York filed Critical Ludwig Institute for Cancer Research New York
Publication of DE69631962D1 publication Critical patent/DE69631962D1/de
Application granted granted Critical
Publication of DE69631962T2 publication Critical patent/DE69631962T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE69631962T 1995-09-12 1996-09-04 Verfahren zur modulation der zell-apoptose Expired - Fee Related DE69631962T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9518611 1995-09-12
GBGB9518611.0A GB9518611D0 (en) 1995-09-12 1995-09-12 Anti-apoptotic factors
US541905 1995-10-10
US08/541,905 US5824551A (en) 1995-09-12 1995-10-10 Method for modulating cell apoptosis
PCT/US1996/014239 WO1997010361A1 (en) 1995-09-12 1996-09-04 Method for modulating cell apoptosis

Publications (2)

Publication Number Publication Date
DE69631962D1 true DE69631962D1 (de) 2004-04-29
DE69631962T2 DE69631962T2 (de) 2005-04-07

Family

ID=26307738

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69631962T Expired - Fee Related DE69631962T2 (de) 1995-09-12 1996-09-04 Verfahren zur modulation der zell-apoptose

Country Status (7)

Country Link
EP (1) EP0850319B1 (de)
JP (1) JPH11513367A (de)
AT (1) ATE262594T1 (de)
AU (1) AU711011B2 (de)
CA (1) CA2231433A1 (de)
DE (1) DE69631962T2 (de)
WO (1) WO1997010361A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050084967A1 (en) 2002-06-28 2005-04-21 Xcyte Therapies, Inc. Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
US9762685B2 (en) 2005-04-27 2017-09-12 Live Nation Entertainment, Inc. Location-based task execution for enhanced data access

Also Published As

Publication number Publication date
ATE262594T1 (de) 2004-04-15
AU6966596A (en) 1997-04-01
EP0850319B1 (de) 2004-03-24
EP0850319A4 (de) 1998-08-05
EP0850319A1 (de) 1998-07-01
CA2231433A1 (en) 1997-03-20
AU711011B2 (en) 1999-10-07
DE69631962T2 (de) 2005-04-07
JPH11513367A (ja) 1999-11-16
WO1997010361A1 (en) 1997-03-20

Similar Documents

Publication Publication Date Title
BR9710570A (pt) Inibidor de adesão de células
DE69933896D1 (de) Verfahren zur Aufrechterhaltung der Gleichförmigkeit von Farbmessgeräten
EE03694B1 (et) Rakuadhesiooni inhibiitorid, neid sisaldavad kompositsioonid ja nende kasutamine
DE69532188D1 (de) Flüssigkeit zur Beschichtung von Zähnen
DK199901518A (da) I form af små molekyler foreliggende inhibitorer af rotamase-enzymaktivitet
DE69500323T2 (de) Antikorrosiver, kathodischer Elektrotauchlack
DE69719409D1 (de) Verfahren zur Reinigung von DNS
EE9700354A (et) Trombiini uued inhibiitorid, nende saamine ja kasutamine
DE69710479D1 (de) Organomineralgel zur dekontamination von oberflächen
EE9900600A (et) Uued amidinoderivaadid ja nende kasutamine trombiini inhibiitoritena
ATE230034T1 (de) Verfahren zur aufreinigung von dns
DE69704189T2 (de) Verfahren zur Reinigung von Wasserstoffperoxid
DE59610713D1 (de) Elektrodenkatheter zur kartierenden erfassung von reizleitungsstrukturen
DE59808699D1 (de) Verwendung von amphiphilen zur dauerhaften verbesserung der klebstoff- und/oder beschichtungs-kompatibilität von polyolefin-basierten formkörpern
DE69937678D1 (de) Verfahren zur schnellen bestimmung von bakterien
DE69934789D1 (de) Verfahren zur bestimmung der antibiotikasensitivität von bakterien
DE69631962D1 (de) Verfahren zur modulation der zell-apoptose
DE69920436D1 (de) Simulierte testverbindung zur untersuchung von drehschlagwerkzeugen
DE69714560T2 (de) Verfahren zur Entmetallisierung von Erdöleinsätzen
DE69941317D1 (de) Verfahren zur Untersuchung von Gasen
DE69927400D1 (de) Pge synthase und verfahren und mitteln zur modulation deren aktivität
DE69709884D1 (de) Verfahren zur auswertung der verschlechterung von isolierpapier
DE19736930B4 (de) Vorrichtung zur Erhöhung der Tragfähigkeit von Brückenträgern
DE3778158D1 (de) Inhibitoren von esterase produzierenden mikroorganismen zur hauptverwendung in deodorants.
DE59700246D1 (de) Verfahren zur galvanotechnischen Metallisierung von Kunststoffoberflächen

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee